Herbal diterpenoids induce growth arrest and apoptosis in colon cancer cells with increased expression of the nonsteroidal anti-inflammatory drug-activated gene

European Journal of Pharmacology

Volumn 559, Issue 1, 2007, Pages 1-13

  Ko, Joshua K S ^a   Leung, Wan C ^a   Ho, Wai K ^a   Chiu, Pauline ^b  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Colon cancer; Growth arrest; NAG 1; Pseudolaric acid B; Triptolide

Indexed keywords

CYCLINE; CYCLOOXYGENASE 2; DITERPENOID; DNA FRAGMENT; HERBACEOUS AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROCASPASE 3; PROTEIN BCL XL; PSEUDOLARIC ACID B; TRIPTOLIDE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL STRAIN HT29; CHROMATIN CONDENSATION; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOSIS; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYTOKINES; DITERPENES; DNA FRAGMENTATION; EPOXY COMPOUNDS; FLOW CYTOMETRY; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; IMMUNOBLOTTING; INDOLES; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 33847069296     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.12.004     Document Type: Article

References (43)

1. Auwerx J. Nuclear receptors I. PPARγ in the gastrointestinal tract: gain or pain?. Am. J. Physiol.: Gastrointest. Liver Physiol. 282 (2002) G581-G585
2. Baek S.J., Horowitz J.M., and Eling T.E. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J. Biol. Chem. 276 (2001) 33384-33392
3. Baek S.J., Kim K., Nixon J.B., Wilson L.C., and Eling T.E. Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol. 59 (2001) 901-908
4. Baek S.J., Wilson L.C., Lee C., and Eling T.E. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J. Pharmacol. Exp. Ther. 301 (2002) 1126-1131
5. Baek S.J., Kim J., Jackson F.R., Eling T.E., McEntee M.F., and Lee S. Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis 25 (2004) 2425-2432
6. Baek S.J., Kim J., Nixon J.B., DiAugustine R.P., and Eling T.E. Expression of NAG-1, a transforming growth factor-β superfamily member, by troglitazone requires the early growth response gene EGR-1. J. Biol. Chem. 279 (2004) 6883-6892
7. Baek S.J., Kim J., Moore S.M., Lee S., Martinez J., and Eling T.E. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol. Pharmacol. 67 (2005) 356-364
8. Barboule N., Lafon C., Chadebech P., Vidal S., and Valette A. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett. 444 (1998) 32-37
9. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.V., and Vogelstein B. Requirement for p53 and p21 to sustain G2/M arrest after DNA damage. Science 282 (1998) 1497-1501
10. Chang W., Kang J.J., Lee K., Wei K., Anderson E., Gotmare S., Ross J.A., and Rosen G.D. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J. Biol. Chem. 276 (2001) 2221-2227
11. Chintharlapalli S., Papineni S., Baek S.J., Liu S., and Safe S. 1,1-bis(3′-indolyl)-1-(p-substituted phenyl)methanes are peroxisome proliferators-activated receptor γ agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1. Mol. Pharmacol. 68 (2005) 1782-1792
12. Fidler J.M., Li K., Chung C., Wei K., Ross J.A., Gao M., and Rosen G.D. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Mol. Cancer Ther. 2 (2003) 855-862
13. Ford H.L., and Pardee A.B. The S phase: beginning, middle, and end: a perspective. J. Cell Biochem., Suppl. 30-31 (1998) 1-7
14. Frese S., Pirnia F., Miescher D., Krajewski S., Borner M.M., Reed J.C., and Schmid R.A. PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. Oncogene 22 (2003) 5427-5435
15. L and cell cycle arrest. Cancer Res. 60 (2000) 2651-2659
16. Gong X., Wang M., Wu Z., Tashiro S., Onodera S., and Ikejima T. Pseudolaric acid B induces apoptosis via activation of c-Jun N-terminal kinase and caspase-3 in HeLa cells. Exp. Mol. Med. 36 (2004) 551-556
17. Gong X.F., Wang M.W., Tashiro S., Onodera S., and Ikejima T. Pseudolaric acid B induces apoptosis through p53 and Bax/Bcl-2 pathways in human melanoma A375-S2 cells. Arch. Pharm. Res. 28 (2005) 68-72
18. 2+ chelator BAPTA/AM. Oncol. Res. 7 (1995) 381-392
19. Jang T.J., Kang H.J., Kim J.R., and Yang C.H. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and-5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Carcinogenesis 25 (2004) 1853-1858
20. Jardat M.S., Noonan D.J., Wu B., Avery M.A., and Feller D.R. Pseudolaric acid analogs as a new class of peroxisome proliferators-activated receptor agonists. Planta Med. 68 (2002) 667-671
21. Jiang X., Wong B.C., Lin M.C., Zhu G., Kung H., Jiang S., Yang D., and Lam S.K. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells. Oncogene 20 (2001) 8009-8018
22. Kiviharju T.M., Lecane P.S., Sellers R.G., and Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer Res. 8 (2002) 2666-2674
23. Lee K.Y., Chang W., Qiu D., Kao P.N., and Rosen G.D. PG490 (triptolide) cooperates with tumor necrosis factor-α to induce apoptosis in tumor cells. J. Biol. Chem. 274 (1999) 13451-13455
24. Lee K.Y., Park J.S., Jee Y.K., and Rosen G.D. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation. Exp. Mol. Med. 34 (2002) 462-468
25. Li E., Clark A.M., and Hufford C.D. Antifungal evaluation of pseudolaric acid B, a major constituent of Pseudolarix kaempferi. J. Nat. Prod. 58 (1995) 57-67
26. Luk J.M., Lai W., Tam P., and Koo M.W.L. Suppression of cytokine production and cell adhesion molecule expression in human monocytic cell line THP-1 by Tripterygium wilfordii polysaccharide moiety. Life Sci. 67 (2000) 155-163
27. McCarty M.F. Current prospects for controlling cancer growth with non-cytotoxic agents - nutrients, phytochemicals, herbal extracts, and available drugs. Med. Hypotheses 56 (2001) 137-154
28. Mueller S., Schittenhelm M., Honecker F., Malenke E., Lauber K., Wesselborg S., Hartmann J.T., Bokemeyer C., and Mayer F. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. Int. J. Oncol. 29 (2006) 471-479
29. O'Connell M.J., and Cimprich K.A. G2 damage checkpoints: what is the turn-on?. J. Cell Sci. 118 Pt 1 (2005) 1-6
30. Pan D., Li Z., Hu C., Chen K., Chang J., and Lee K. The cytotoxic principles of Pseudolarix kaempferi: pseudolaric acid-A and-B and related derivatives. Planta Med. 56 (1990) 383-385
31. Ray G., Dhar G., van Veldhuizen P.J., Banerjee S., Saxena N.K., Sengupta K., and Banerjee S.K. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradial in prostate cancer cells is mediated through multiple signal transduction pathways. Biochemistry 45 (2006) 3703-3713
32. Sačková V., Fedoročko P., Szilárdiová B., Mikeš J., and Kleban J. Hypericin-induced photocytotoxicity is connected with G2/M arrest in HT-29 and S-phase arrest in U937 cells. Photochem. Photobiol. 82 (2006) 1285-1291
33. Shamon L.A., Pezzuto J.M., Graves J.M., Mehta R.R., Wangcharoentrakul S., Sangsuwan R., Chaichana S., Tuchinda P., Cleason P., and Reutrakul V. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett. 112 (1997) 113-117
34. Shih S.C., and Stutman O. Cell cycle-dependent tumor necrosis factor apoptosis. Cancer Res. 56 (1996) 1591-1598
35. Shishodia S., Sethi G., Konopleva M., Andreeff M., and Aggarwal B.B. A synthetic triterpenoid, CDDO-Me, inhibits IκBα kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor κB-regulated gene products in human leukemia cells. Clin. Cancer Res. 12 (2006) 1828-1838
36. Solomon M.J., Glotzer M., Lee T.H., Philippe M., and Kirschner M.W. Cyclin activation of p34cdc2. Cell 63 (1990) 1013-1024
37. Takahashi N., Kawada T., Goto T., Tamamoto T., Taimatsu A., Matsui N., Kimura K., Saito M., Hosokawa M., Miyashita K., and Fushiki T. Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 514 (2002) 315-322
38. Vermeulen K., van Bockstaele D.R., and Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36 (2003) 131-149
39. Walker D.H., and Maller J.L. Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature 354 (1991) 314-317
40. Wilson L.C., Baek S.J., Call A., and Eling T.E. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer 105 (2003) 747-753
41. Wong V.K.W., Chiu P., Chung S.S.M., Chow L.M.C., Zhao Y., Yang B.B., and Ko B.C.B. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clin. Cancer Res. 11 (2005) 6002-6011
42. Yang S., Chen J., Guo Z., Xu X., Wang L., Pei X., Yang J., Underhill C.B., and Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2 (2003) 65-72
43. Zhou B.N., Ying B.P., Song G.Q., Chen Z.X., Han J., and Yan Y.F. Pseudolaric acids from Pseudolarix kaempferi. Planta Med. 47 (1983) 35-38